PharmaTher Partners with Craft Health to Personalize 3D Printed Peptides

The Toronto-based PharmaTher Holdings Ltd. has launched Personaliz3D Peptides™, a division built to develop and commercialize personalized peptide products using 3D printing and artificial intelligence. Two days later, the specialty pharmaceutical company announced a collaboration with Singapore-based Craft Health Pte. Ltd. to evaluate CraftMake™, pharmaceutical 3D printer, as the manufacturing platform behind that strategy.

The announcements outline a new personalized-medicine division, followed by the additive manufacturing technology selected to build it. The collaboration will focus on developing peptide formulations and testing CraftMake™ as a reproducible platform for producing personalized doses, combination formulations, controlled-release designs and alternative dosage forms.

Gummies made by CraftMake

“Patients and healthcare providers should not have to rely on a one-size-fits-all approach when individual treatment needs can differ significantly,” said Fabio Chianelli, Chairman and Chief Executive Officer of PharmaTher. “Personaliz3D Peptides™ is being built to make personalized peptide care more precise, convenient, connected and manufactured under strict quality and GMP-aligned standards.”